All injection pens Articles

Drug-maker Novo Nordisk to spend $4.1bn on construction of US Wegovy facility
Premium Content
Danish drug-maker Novo Nordisk is to spend $4.1 billion to build a new US facility to fill injection pens for its popular weight-loss treatment Wegovy